Steady UDG gets a clean bill of health

I held my nerve when UDG Healthcare’s share price plummeted, and the recent annual report vindicated my faith, with plenty of cause for medium-term optimism

2nd December, 2018
The annual general meeting of UDG in 2016: members of the board have shown an impressive financial commitment to the company Pic: Fergal Phillips

Until a few months ago, UDG Healthcare was the second-best performing asset in my equity portfolio. In February 2015, I bought the shares at £4.16. They hit a peak at £9.40 in May this year so, notwithstanding the drop in sterling since my purchase, I wasn’t complaining. With a sterling book profit of 125 per cent, the currency loss against the euro was easily absorbed.

However, the recent downward trend in the company’s share price...

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

Private rental sector remains strong despite Covid-19

How the programme for government will shape housing

Comment: US must defuse Covid-19’s ticking time bomb of debt

Comment: The recovery will be more U than V-shaped